Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides?
Shafran, S.D.; Conley, J.M.
Canadian Journal of Cardiology 13(11): 1017-1019
1997
ISSN/ISBN: 0828-282X PMID: 9413231 Document Number: 480309
Document emailed within 1 workday
Related Documents
Imai, S.; Matsubara, T.; Hori, T.; Nakagawa, I.; Ozaki, K.; Hatada, K.; Mezaki, T.; Nasuno, A.; Kubota, K.; Tanaka, T.; Aizawa, Y. 2001: Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries Journal of Cardiology 37(6): 293-299Melnick, S.L.; Shahar, E.; Folsom, A.R.; Grayston, J.T.; Sorlie, P.D.; Wang, S.P.; Szklo, M. 1993: Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators American Journal of Medicine 95(5): 499-504
Sumarokov, A.B.; Pankratova, V.N.; Liakishev, A.A.; Avdeeva, I.I. 1999: The studying of Chlamydia pneumoniae in atherosclerosis Klinicheskaia Meditsina 77(10): 4-7
Grayston, J.T.; Kuo, C.C.; Campbell, L.A.; Benditt, E.P. 1993: Chlamydia pneumoniae, strain TWAR and atherosclerosis European Heart Journal 14(Suppl): 66-71
Grabczewska, Z.; Nartowicz, E. 1999: Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis Przeglad Lekarski 56(9): 584-587
Fudal, M.; Wilczewski, P.ła. 2004: Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date? Wiadomosci Lekarskie 57(3-4): 151-155
Azzouzi, N.; Elhataoui, M.; Bakhatar, A.; Takourt, B.; Benslimane, A. 2005: Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma Annales de Biologie Clinique 63(2): 179-184
Parada, M.T.; Kauffmann, R. 2000: Acute coronary syndrome associated with Chlamydia pneumoniae pneumonia in two cases Revista Medica de Chile 128(2): 201-205
Gajek, J.; Choroszy-Król, I.; Zyśko, D.; Teryks-Wołyniec, D.; Halawa, B.ł 2003: The influence of Chlamydia pneumoniae infection on acute coronary syndromes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(85): 20-23
Leowattana, W.; Mahanonda, N.; Bhuripanyo, K.; Pokium, S.; Kiartivich, S. 2000: Chlamydia pneumoniae antibodies and angiographically demonstrated coronary artery disease in Thailand Journal of the Medical Association of Thailand 83(9): 1054-1058
Leowattana, W.; Mahanonda, N.; Bhuripunyo, K.; Leelarasamee, A.; Pokum, S.; Suwimol, B. 1999: The prevalence of Chlamydia pneumoniae antibodies in Thai patients with coronary artery disease Journal of the Medical Association of Thailand 82(8): 792-797
Khasaev, A.S.; Gadzhieva, Z.G. 2003: Relationship between Chlamydia pneumoniae and classical risk factors of coronary heart disease Kardiologiia 43(10): 32-34
Al-Ghamdi, A.; Jiman-Fatani, A.A.; El-Banna, H. 2011: Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease Pakistan Journal of Pharmaceutical Sciences 24(2): 95-101
Tauzeeh, S.M. 1997: Chlamydia pneumoniae infection and coronary heart disease. other infections might have role in South Asians Bmj 315(7121): 1539
Leowattana, W.; Bhuripanyo, K.; Singhaviranon, L.; Akaniroj, S.; Mahanonda, N.; Samranthin, M.; Pokum, S. 2001: Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial Journal of the Medical Association of Thailand 84 Suppl. 3: S669-S675
Patel, P.; Mendall, M.A.; Carrington, D.; Strachan, D.P.; Leatham, E.; Molineaux, N.; Levy, J.; Blakeston, C.; Seymour, C.A.; Camm, A.J. 1995: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors BMJ 311(7007): 711-714
Song, H.; Tasaki, H.; Yashiro, A.; Okazaki, M.; Ioka, T.; Taniguchi, H.; Nakashima, Y. 2001: Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure Clinical Nephrology 56(5): 346-352
Adiloglu, A.K.; Ocal, A.; Can, R.; Duver, H.; Yavuz, T.; Aridogan, B.C. 2005: Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation Saudi Medical Journal 26(7): 1068-1074
Kuczaj, A.; Stryjewski, P.J.; Fudal, M.; Domal-Kwiatkowska, D.; Ryfiński, B.; Sliupkas-Dyrda, E.; Smolik, S.; Węglarz, L.; Mazurek, U.; Nowalany-Kozielska, E. 2016: The prevalence of Chlamydia pneumoniae in the aortic wall and in peripheral blood of patients scheduled for coronary artery bypass grafting Journal of Biological Regulators and Homeostatic Agents 30(2): 433-440
Chaudhury, A.; Rajasekhar, D.; Latheef, S.A.A.; Subramanyam, G. 2003: Seropositivity of Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in a South Indian population Indian Heart Journal 55(4): 384